Lilly introduced Mounjaro, a drug for diabetes and weight loss, in India earlier this year, ahead of rival Novo Nordisk. Mounjaro has sold more than 81,570 units in the country, generating ...

--Eli Lilly and Company today announced detailed results from ACHIEVE-1, a Phase 3 trial evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes and ...

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results for the ...

The highest dose helped patients with Type 2 diabetes lose 7.6% of their body weight, during the 40-week study, according to data presented Saturday at the American Diabetes Association conference in ...

Shopping Tips and Deals There’s a dog-friendly leather sectional sofa from Albany Park on sale for over $900 off Updated: Jun. 20, 2025, 1:42 p.m. | Published: Jun. 20, 2025, 1:40 p.m.

Shopping There’s a dog-friendly leather sectional sofa from Albany Park on sale for over $900 off Updated: Jun. 20, 2025, 1:42 p.m. | Published: Jun. 20, 2025, 1:40 p.m.

FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, are seen in a fridge at a health clinic in Hyderabad, India, April 14, 2025.

In other recent news, Eli Lilly announced its acquisition of Verve Therapeutics for approximately $1.0 billion upfront, with a potential total value of $1.3 billion if certain development ...

I’m that loud”: How Lilly Singh became the Toronto Tempo’s chief hype officer Singh has gone all in with Toronto’s new WNBA team: part owner, unofficial head cheerleader and bringer of 14 ...